Who We Are
Developing Proprietary Biosimilar Pipeline
We are developing a vast pipeline of several proprietary biosimilars through experienced process optimization, an unwavering commitment to quality, and with innovative/cost-effective manufacturing infrastructure.
Collaboration & Licensing of Innovative Biologics
We license-in innovative new molecules for co-development that we believe offer long-term benefits and can address global unmet medical needs. In paving the way to becoming an industry leader in biologics manufacturing, innovation is key.
Founded in 2012, Eden Biologics is an innovator in biopharmaceuticals that utilizes breakthrough engineering and process technologies to provide high quality and affordable biosimilar medicines to patients in need and a formidable CDMO player for global and regional clients. Eden has submitted IND/CTA’s to over 20+ countries/regions and has passed numerous Regulatory Audits/Inspections, including from the Taiwan FDA and EU Qualified Person (QP).
EDEN’s vision is to improve global healthcare by increasing the availability of biotechnology medicines and making them affordable for ALL in need. The individual color blocks in our logo represents the pioneering aspects of our company: innovative technologies, state-of-the-art equipment, professional leadership and experienced workforce. The resulting “E” gels these together. If you zoom out, the logo includes green hills, golden fields and a dazzling sun as we envision building a better, healthier world through EDEN.